Journal of Immunological Techniques in Infectious Diseases is a subscription based scientific Journal that provides a range of options to individuals and university libraries to purchase our articles and also permits unlimited Internet Access to complete Journal content. However JIDIT has recently started following Hybrid Model of publication of articles. Under hybrid model, journal is giving option to authors to choose their mode of publishing; either Open Access (making individual articles freely available online) or Subscription (article access restricted to journal subscribers).
JIDIT accepts wide range of articles including research, review, short communication, case report, rapid communication, letter to the editor, conference proceedings etc. The journal has a sound Editorial Board of experts in their fields. Articles submitted by authors are evaluated by Editors and a group of peer review experts in the field to ensure that the accepted and published articles are of high quality, reflect solid scholarship in their fields, and that the information they contain is accurate, reliable and beneficial to the scientific community.
Journal of Immunological Techniques in Infectious Diseases is organizing & supporting 4th International Conference on Vaccines & Vaccination which is going to be held during September 24-26, 2014 at Valencia, Spain with the theme of Recent Innovations and Benchmark Practices in Vaccines & Vaccination.
Syphilis and leprosy have cutaneous manifestations with great lesional polymorphism with subsequent difficult differential diagnosis. Both have additional tests that, in certain situations, are inconclusive, making it difficult to confirm the clinical diagnosis. In medical literature there are several clinical cases reported in which patients with syphilis were erroneously diagnosed and treated as having leprosy. Physicians need to maintain a high index of suspicion for the diagnosis of syphilis.
Late-Onset Prosthetic Valve Fungal Endocarditis due to Candida albicans: A Case Report and Review of Literature from India
The incidence of prosthetic valve endocarditis (PVE) is 1-4%. Fungal endocarditis (FE) is an uncommon complication of valve replacement surgery. The incidence of PVE is highest within the first 12 months following surgery. We report here a fatal case of late-onset fungal endocarditis after 15 years of mitral valve replacement for which administration of amphotericin B is crucial for survival of patients.
Prospect of CD52 Targeted Alemtuzumab in Treatment of CNS Demyelination in Multiple Sclerosis
The choice of humanized monoclonal antibody is a novel therapeutic approach for autoimmune relapsing remitting multiple sclerosis (RRMS). In addition to anti-alpha-4 integr in monoclonal antibody Natalizumab, introduction of CAMPATH-1 (Alemtuzumab) is a fairly new approach in MS research and clinical trials. The uniqueness of this monoclonal antibodyis that it depletes CD52 marker expressing circulatory T and B cells including monocytes and dendritic cells. However, it has no impact on progenitor cells. Thus, the use of Alemtuzumab has gained importance in delaying rejection in allograft during transplantation.